Anthony Sun

  • Partner, Aisling Capital, New York City, US

    Dr. Sun joined Fund I in 2002 and currently serves as a Partner. Previously, Dr. Sun was an Adjunct Instructor of Medicine at the Hospital of the University of Pennsylvania. 

Dr. Sun currently serves as a director of CeNeRx BioPharma, Inc., Dynova Laboratories, Inc., HerbalScience, Inc., and Paratek Pharmaceuticals, Inc. Previously he served as a director of MAP Pharmaceuticals, Inc. 

Dr. Sun received his M.D. from Temple University School of Medicine with A.O.A. honors. He received his M.B.A. from The Wharton School at the University of Pennsylvania, and his B.S. in Electrical Engineering from Cornell University. In addition, he is Board Certified in Internal Medicine.

  • Conference Info:


    Date: June 26-27, 2013
    Location: The Metropolitan Club, New York City

    Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.

    View the Schedule!

    View the Agenda!